These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 2573420)

  • 1. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
    Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
    Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
    Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.
    Kreipe H; Feist H; Fischer L; Felgner J; Heidorn K; Mettler L; Parwaresch R
    Cancer Res; 1993 Apr; 53(8):1956-61. PubMed ID: 8096798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proto-oncogene amplification and human breast tumor phenotype.
    Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
    Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
    Yao M; Shuin T; Misaki H; Kubota Y
    Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
    Nikiforova IF
    Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease.
    Zhou DJ; Ahuja H; Cline MJ
    Oncogene; 1989 Jan; 4(1):105-8. PubMed ID: 2915899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.